share_log

Vaccinex Shares Are Trading Lower. The Company Announced Results of Its Early Stage SIGNAL-AD Clinical Trial of Pepinemab Antibody in AD.

Benzinga ·  14:58
Vaccinex Shares Are Trading Lower. The Company Announced Results of Its Early Stage SIGNAL-AD Clinical Trial of Pepinemab Antibody in AD.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment